A review of research on eligibility criteria for clinical trials

Qianmin Su1, Gaoyi Cheng2, Jihan Huang3

  • 1Department of Computer Science, School of Electronic and Electrical Engineering, Shanghai University of Engineering Science, No. 333 Longteng Road, Shanghai, 201620, China. suqm@sues.edu.cn.

Insights

This study reviews cutting-edge research on clinical trial eligibility criteria. Optimizing these criteria using big data and AI is crucial for successful patient recruitment and faster trial completion.

Area of Science:

  • Clinical Research
  • Biomedical Informatics
  • Data Science

Background:

  • Eligibility criteria are critical for clinical trial success, directly impacting recruitment and outcomes.
  • Inappropriate criteria often lead to insufficient patient enrollment, a major cause of trial failure.
  • Understanding current research trends is essential for advancing clinical trial design.

Purpose of the Study:

  • To systematically review and analyze the latest research on clinical trial eligibility criteria.
  • To provide a clear overview of the frontier research landscape in this field.
  • To identify key challenges and future directions for improving eligibility criteria.

Main Methods:

  • Conducted a comprehensive investigation of research on clinical trial eligibility criteria using academic platforms like arXiv and NIH.
  • Classified and organized collected papers to present a structured analysis of the field.
  • Focused on emerging technologies and big data approaches in eligibility criteria research.

Main Results:

  • Identified four main research aspects: natural language processing, patient pre-screening, standard evaluation, and clinical trial query.
  • Highlighted the shift towards utilizing new technologies and big data for studying eligibility criteria.
  • Noted challenges including complex disease concepts, dataset selection, and result validation.

Conclusions:

  • Formulating more scientific and reasonable eligibility criteria is key to accelerating clinical trials.
  • Future research should concentrate on artificial intelligence algorithms, databases, knowledge graphs, and dictionaries.
  • Advancements in these areas will enhance the efficiency and success rate of clinical trials.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
200
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
335